Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06023537 · ClinicalTrials.gov registry record · NA

Using Technology to Investigate Lapses in a Weight Loss Program Among Individuals With Overweight and Obesity

A NA study of Obesity and Weight Loss, sponsored by Williams College.

Active
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT06023537: Active NA study of Obesity and Weight Loss, sponsored by Williams College.

NCT06023537 is a NA study of Obesity and Weight Loss that is active but no longer recruiting, run by Williams College. The registered enrollment target is 100 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06023537, a NA study of Obesity and Weight Loss, is active but no longer recruiting, sponsored by Williams College.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

Approximately 70% of American adults have overweight/obesity, which increases risk of major medical issues and preventable death (Abdelaal et. al, 2017). Many individuals with overweight/obesity attempt to lose weight through behavioral strategies, e.g., adopting a reduced-calorie diet and/or increased physical activity. However, it is exceedingly difficult to consistently adhere to a reduced-calorie diet and high levels of physical activity; as such, most individuals attempting to lose weight via these methods experience repeated instances of non-adherence, i.e., dietary and physical activity lapses. These lapses are a core driver of weight loss failure, undermining individuals' ability to achieve weight control (Forman et al, 2017). As such, it is important to understand what predicts these lapses, which in turn allows for better lapse prevention. The current study proposes to measure these risk factors in an ecologically valid manner, i.e., in the moment they occur and in the context of individuals' everyday lives, using advanced technology. Specifically, the current study will use ecological momentary assessments (EMA; brief, repeated surveys delivered in one's natural environment, typically via a smartphone) and sensor technology (e.g., Fitbit and sensors on smartphone devices) to measure momentary risk factors of dietary and physical activity lapse, as well as the lapses themselves. Findings from this research project will lay the groundwork for a sophisticated just-in-time adaptive intervention (JITAI), a tailored, personalized intervention that targets momentary risk factors (e.g., cravings) via in-the-moment support, thereby reducing lapse occurrence and improving adherence to behavioral weight control prescriptions.

Primary Outcome

Physical activity lapse/intention-behavior gap will be measured using ecological momentary assessment (EMA; brief, smartphone-delivered surveys) and accelerometers. EMA surveys will be delivered in 2-week bursts at the beginning, middle, and end of treatment. There will be 6 EMA surveys delivered every 2-3 hours throughout the day. Each EMA survey will ask about the participant's intention to engage in moderate-to-vigorous physical activity (MVPA) in the next 2-3 hours and actual engagement in M

Conditions Studied

Interventions

  • BEHAVIORAL Behavioral weight loss program

Study Locations (1)

Massachusetts

  • Health Lab, Psychology Department, Williams College - Williamstown

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2023-07-11
Est. Completion 2025-08-14
Phase NA
Williams College

1 total trials

What the registry record for NCT06023537 still lists

NCT06023537 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (88% lower).

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Behavioral weight loss program is the first listed.

NCT06023537 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06023537 about?

NCT06023537 is a clinical study titled "Using Technology to Investigate Lapses in a Weight Loss Program Among Individuals With Overweight and Obesity". Approximately 70% of American adults have overweight/obesity, which increases risk of major medical issues and preventable death (Abdelaal et. al, 2017). Many individuals with overweight/obesity attempt to lose weight through behavioral strategies, e.g., adopting a reduced-calorie diet and/or increa...

What is the current status of trial NCT06023537?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-07-11. Estimated completion is 2025-08-14.

What conditions does trial NCT06023537 study?

This clinical trial studies the following conditions: Obesity, Weight Loss.

What interventions are being tested in trial NCT06023537?

The interventions under investigation include: Behavioral weight loss program (BEHAVIORAL).

Who is sponsoring clinical trial NCT06023537?

This trial is sponsored by Williams College, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06023537 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06023537's enrollment target sits among peer trials

100 478th of 1053 higher than 555 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06023537, the US trial registry maintained by the National Library of Medicine. NCT06023537 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.